CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 41 filers reported holding CIDARA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $60,000 | -36.2% | 35,496 | 0.0% | 0.01% | -44.4% |
Q1 2019 | $94,000 | +13.3% | 35,496 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $83,000 | -56.3% | 35,496 | -17.9% | 0.01% | -36.8% |
Q3 2018 | $190,000 | -15.6% | 43,209 | 0.0% | 0.02% | -5.0% |
Q2 2018 | $225,000 | +30.1% | 43,209 | 0.0% | 0.02% | 0.0% |
Q1 2018 | $173,000 | -53.4% | 43,209 | -20.9% | 0.02% | -63.0% |
Q4 2017 | $371,000 | +62.0% | 54,596 | +93.0% | 0.05% | +42.1% |
Q3 2017 | $229,000 | -16.7% | 28,290 | -22.8% | 0.04% | -33.3% |
Q2 2017 | $275,000 | – | 36,648 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |